Canada markets closed

Canntab Therapeutics Limited (TBF1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.00050.0000 (0.00%)
At close: 08:00AM CET
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-05-31
2021-05-31
2020-05-31
2019-05-31
Total Revenue
297.356
293.362
0
133.334
239.999
Cost of Revenue
212.873
223.894
-
-
-
Gross Profit
84.483
69.468
-
-
-
Operating Expenses
Research Development
188.512
205.031
80.357
105.746
128.144
Selling General and Administrative
2,481
2,827
2,704
2,339
2,437
Total Operating Expenses
3,226
3,667
3,331
2,749
2,742
Operating Income or Loss
-3,141
-3,597
-3,331
-2,616
-2,502
Interest Expense
659.169
566.672
188.722
-
-
Total Other Income/Expenses Net
247.254
474.834
-900.3
-
-
Income Before Tax
-3,553
-3,689
-4,420
-2,607
-2,459
Income from Continuing Operations
-3,553
-3,689
-4,420
-2,607
-2,459
Net Income
-3,553
-3,689
-4,420
-2,607
-2,459
Net Income available to common shareholders
-3,553
-3,689
-4,420
-2,607
-2,459
Basic EPS
-
-0.10
-0.13
-0.10
-0.10
Diluted EPS
-
-0.10
-0.13
-0.10
-0.10
Basic Average Shares
-
37,724
34,553
27,169
25,299
Diluted Average Shares
-
37,724
34,553
27,169
25,299
EBITDA
-
-2,488
-3,685
-2,320
-2,421